Better Therapeutics, Inc. (BTTX)

NASDAQ: BTTX · IEX Real-Time Price · USD
1.47
-0.07 (-4.55%)
At close: May 20, 2022 4:00 PM
1.46
-0.01 (-0.68%)
After-hours:May 20, 2022 7:56 PM EDT

Ratios and Metrics (Trailing)

Millions USD. Fiscal year is Jan - Dec.
Period EndedCurrent2022-03-312021-12-312021-09-302021-06-302021-03-31
Market Capitalization
3547110757575
Market Cap Growth
--38.02%----
Enterprise Value
13257911110175
PE Ratio
--1.06-2.72-2.53-3.85-6.38
PS Ratio
----9.00-10.00-18.00
PB Ratio
1.271.702.99-1.31-1.67-
EV/Sales Ratio
----9.00-10.00-18.00
Debt / Equity Ratio
0.350.350.26-0.68-0.620
Debt / EBITDA Ratio
---0.25--1.600
Debt / FCF Ratio
---0.30--2.150
Current Ratio
9.869.869.561.141.44-
Return on Equity (ROE)
-465.40%-269.20%---
Return on Assets (ROA)
-158.20%-158.20%-140.70%---
Return on Capital (ROIC)
-209.90%-209.90%-357.20%---
Earnings Yield
-127.58%-94.73%-36.75%-39.51%-25.94%-15.68%
FCF Yield
---29.06%--17.22%-
Buyback Yield / Dilution
-119.12%-119.12%-30.48%---125.24%
Total Shareholder Return
-119.12%-119.12%-30.48%0.00%0.00%-125.24%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).